147
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes

, , , , &
Pages 233-236 | Received 28 Dec 2016, Accepted 19 Apr 2017, Published online: 30 May 2017
 

Acknowledgements

The authors would like to thank the patient and related control-individuals for participation in this study. This work was supported in part by the National Natural Science Foundation of China (No. 81500171).

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1323269

Additional information

Funding

This work was supported in part by the National Natural Science Foundation of China (No. 81500171).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.